Genzyme increasing R&D presence in San Antonio area
13th Nov 2006, 22:02 GMT
Genzyme Oncology is investing $1.9 mln to renovate and expand its facilities in the TX Research Park.
Genzyme increasing R&D presence in San Antonio area related news:
- Genzyme increasing research and development presence in San Antonio area — bizjournals.com Real Estate:Construction headlines
- Genzyme Increasing Research and Development and Amgen Releases Long-Term Enbrel Data — Financial News USA (OTC: FNWU)
- Water plan's soaring cost raises questions for SAWS. — Environmental Health News
- Perry: council to promote economic growth — KLTV - Local and National News
- Duncan Spurs San Antonio Past Rockets — www.heraldsun.com
- Baptist foundation grants $3.2 million to local health groups — Latest news from San Antonio Business Journal
- San Antonio Spurs forward Fabricio Oberto (L) of Argentina goes ... — Sports Photos - Reuters on Yahoo! News Photos
- San Antonio Spurs center Francisco Elson (16) of the Netherlands ... — Sports Photos - Reuters on Yahoo! News Photos
- Houston Rockets center Yao Ming of China celebrates as San Antonio ... — Sports Photos - Reuters on Yahoo! News Photos
- Plan Aims to Promote Development While Preserving South Side's Rural Character — RedOrbit News - Science
Latest news from Radiology News from StratCenter.com:
- Eisai Breaks Ground for New Oncology Facility in Research Triangle Park
- Ashok Gupta, MD Joins the Physician Team at Desert Radiologists
- AMICAS Offers Free PACS Webinar for RSNA Attendees
- Enrollment Completed Utilizing Cytori's Adipose-Derived Stem Cell Technology for Treatment of Breast Cancer Complications
- Groundbreaking for Cancer Center on Premier Healh Campus - Middletown
- BSD Medical Sends Message of Hope at Largest Conference of US Radiation Oncologists
- Volcano to Offer 7.5M Shares
- Nautilus Biotech and Creabilis Therapeutics Achieve Technical Milestone in Collaboration to Improve HMGB1 Box A for the Treatment of Rage- and HMGB1-Related Pathologies.
- Adherex Reports Q3 2006 Financial Results
- Stereotaxis to Present at Bear Stearns 2006 SMid-Cap Investor Conference